Clinically relevant outcomes in dental clinical trials: challenges and proposals

被引:30
|
作者
Pannuti, Claudio Mendes [1 ]
Sendyk, Daniel Isaac [1 ]
das Gracas, Yasmin Teixeira [1 ]
Takai, Sandra Lie [1 ]
Aragao Saboia, Vicente de Paulo [2 ]
Romito, Giuseppe Alexandre [1 ]
Mendes, Fausto Medeiros [3 ]
机构
[1] Univ Sao Paulo, Sch Dent, Dept Stomatol, Sao Paulo, SP, Brazil
[2] Univ Fed Ceara UFC, Sch Dent, Dept Restorat Dent, Fortaleza, Ceara, Brazil
[3] Univ Sao Paulo, Sch Dent, Dept Pediat Dent, Sao Paulo, SP, Brazil
来源
BRAZILIAN ORAL RESEARCH | 2020年 / 34卷
关键词
Clinical Trial; Treatment Outcome; Biomarkers; SURROGATE END-POINTS; TOOTH LOSS; RANDOMIZED-TRIALS; CHRONIC PERIODONTITIS; FLUORIDE VARNISH; IMPLANTS; PROTOCOLS; HEALTHY;
D O I
10.1590/1807-3107bor-2020.vol34.0073
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The impact of clinical trials on patient care depends on the outcomes that they evaluate. In Dentistry, many trials use outcomes that are important to clinicians, but not to the patients. Thus, the aim of the present manuscript is to present an overview of the limitations, challenges, and proposals on the use of clinically relevant outcomes (CRO) in dental trials. Clinically relevant outcomes are variables that directly measure how the patient feels, functions, or survives. Some CROs, such as tooth loss, implant failure, and restorations failure require many years to occur and the number of events is low. The adoption of these variables as primary outcomes results in challenges for the researchers, such as use of large sample sizes and long follow-up periods. Surrogate outcomes, such as biomarkers, radiographic measurements and indexes, are frequently used to replace CROs. However, they present many limitations, since the effect of the treatment on a surrogate does not necessarily reflect a change in the clinical outcome. Some proposals for the adoption of CROs are presented, such as the development of core outcome sets within each dental specialties and the organization of multi-center clinical trials.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Toward clinically relevant clinical trials
    Arnold, LE
    Hoagwood, K
    Jensen, PS
    Vitiello, B
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (01) : 135 - 142
  • [2] Clinical trials: evidence based and clinically relevant or not?
    De Hert, Stefan G.
    Van der Linden, Philippe J.
    CURRENT OPINION IN ANESTHESIOLOGY, 2009, 22 (01) : 68 - 70
  • [3] No clinically relevant hypersensitivity reactions in clinical trials with tralokinumab in asthma
    Carlsson, Mats
    Braddock, Martin
    Li, Yuling
    Wang, Jihong
    Xu, Weichen
    Colice, Gene
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [4] Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages Implications for Clinical Alzheimer Trials
    Borland, Emma
    Edgar, Chris
    Stomrud, Erik
    Cullen, Nicholas
    Hansson, Oskar
    Palmqvist, Sebastian
    NEUROLOGY, 2022, 99 (11) : E1142 - E1153
  • [5] Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials
    Tandon, P.
    Bain, V. G.
    Tsuyuki, R. T.
    Klarenbach, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (09) : 1017 - 1028
  • [6] Evidence-Based and Clinically Relevant Outcomes for Hemorrhage Control Trauma Trials
    Holcomb, John B.
    Moore, Ernest E.
    Sperry, Jason L.
    Jansen, Jan O.
    Schreiber, Martin A.
    del Junco, Deborah J.
    Spinella, Philip C.
    Sauaia, Angela
    Brohi, Karim
    Bulger, Eileen M.
    Cap, Andrew P.
    Hess, John R.
    Jenkins, Donald
    Lewis, Roger J.
    Neal, Matthew D.
    Newgard, Craig
    Pati, Shibani
    Pusateri, Anthony E.
    Rizoli, Sandro
    Russell, Robert T.
    Shackelford, Stacy A.
    Stein, Deborah M.
    Steiner, Marie E.
    Wang, Henry
    Ward, Kevin R.
    Young, Pampee
    ANNALS OF SURGERY, 2021, 273 (03) : 395 - 401
  • [7] Phage therapeutic delivery methods and clinical trials for combating clinically relevant pathogens
    Selim, Heba Mohammed Refat M.
    Gomaa, Fatma Alzahraa M.
    Alshahrani, Mohammad Y.
    Morgan, Radwa N.
    Aboshanab, Khaled M.
    THERAPEUTIC DELIVERY, 2024,
  • [8] An Appraisal of Clinically Meaningful Outcomes Guidelines for Oncology Clinical Trials
    Kumar, Hemanth
    Fojo, Tito
    Mailankody, Sham
    JAMA ONCOLOGY, 2016, 2 (09) : 1238 - 1240
  • [9] Clinically relevant sample size calculations for trials
    Papageorgiou, Spyridon N.
    JOURNAL OF ORTHODONTICS, 2019, 46 (02) : 178 - 180
  • [10] Evaluation of efficacy measures in clinical trials for Alzheimer's disease: Does psychometric test performance predict clinically relevant outcomes?
    Sano, M
    Growdon, J
    Thomas, R
    Ernesto, C
    Schafer, K
    Woodbury, P
    Grundman, M
    Thal, L
    NEUROLOGY, 1996, 46 (02) : 14004 - 14004